TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Bioverativ Inc (NASDAQ:BIVV) Investor Lawsuit Filed Against Acquisition By Sanofi

  • If you purchased shares of Bioverativ Inc (NASDAQ:BIVV), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

March 5, 2018 - The case was dismissed. February 15, 2018 - An investor, who currently holds shares of Bioverativ Inc (NASDAQ:BIVV), filed a lawsuit in effort to halt the proposed takeover of Bioverativ Inc. by Sanofi. Waltham, MA based Bioverativ Inc. (Bioverativ) is a biotechnology company. The Company is focused on the discovery, research, development and commercialization of the...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: